Compare places
Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.
Choose up to three clusters
- London
- Cambridge
- Oxford
- Manchester
- Birmingham & the West Midlands
- Bristol & Bath
- Sheffield & Rotherham
- Leeds & West Yorkshire
- Liverpool City Region
- Newcastle & the North East
- Teesside & the Humber
- Edinburgh
- Glasgow & the Central Belt
- Belfast
- Cardiff & South Wales
- Southampton & Portsmouth
- Cornwall & Plymouth
- Nottingham & Derby
- Norwich & the East
Side by side
| Dimension | CambridgeEast of England | Newcastle & the North EastNorth East | Leeds & West YorkshireYorkshire and the Humber |
|---|---|---|---|
| Sectors | Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies | Clean Energy, Mobility & Transport Technology, Advanced Manufacturing Supporting: Life Sciences, Digital Technologies, Robotics & Autonomous Systems | Life Sciences, Digital Technologies, Financial Technology Supporting: Artificial Intelligence, Advanced Manufacturing, Creative Industries |
| Research |
|
|
|
| Companies |
| Not recorded on the map. |
|
| Infrastructure |
University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability. |
Offshore renewable test facilities, battery production investment and university research centres. | Not recorded on the map. Health data infrastructure, teaching hospitals and university research facilities. |
| Capital | Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand. | Infrastructure and development finance, with limited venture capital relative to industrial scale. | Financial services depth locally, but early-stage health technology capital remains limited. |
| Government programmes | No place-based designation recorded. |
| No place-based designation recorded. |
| What exists | Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines. | Offshore renewable energy testing at national scale, battery and electrification investment, ageing and life sciences research and a strong engineering base. | National health data organisations, medical technology, a large financial and professional services base and a research university with data and materials strength. |
| What's missing · UKIZ interpretation | Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth. | Supply chain retention. Britain builds offshore capacity while importing much of the equipment; local firms often serve as installers rather than manufacturers. | A clear route for companies to work with health data at scale, and clinical adoption pathways that move faster than pilot projects. |
| What could connect · UKIZ interpretation | Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country. | Offshore testing capability connected to Teesside and Humber industrial land, Sheffield manufacturing research and domestic energy buyers — an energy supply chain rather than an energy market. | Leeds health data capability connected to Manchester clinical research and to medical technology manufacturing, giving companies discovery, evidence and production in one region. |
| UKIZ relevance | Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery. | The region has the industrial land, the ports and the skills base. The proposed North East mission focuses on retaining the supply chain, not only the assembly. | Health data at population scale is a national asset. The proposed Manchester mission and Leeds capability are complementary rather than competing. |
| Last verified | 15 August 2026 | 15 August 2026 | 15 August 2026 |
Proposed by UKIZ · independent · not a government designation